biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Part-time CFO

<< Previous

Bullboard Posts

Next >>

Comment by frohlir944on Oct 15, 2021 7:01pm

155 Views

Post# 34012447

RE:RE:RE:RE:RE:RE:Part-time CFO

Wow,
you just want to prove over and over again what a horrible human being you are. Every time I think you couldn't possibly be worse, you prove me wrong yet again. Feel very sorry for your family or anyone around you.

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo